Novel e-Lung CT biomarkers combine to provide higher prognostic discrimination than FVC in patients with non-IPF fibrotic interstitial lung disease

被引：0
|
作者：
George, Peter [1 ]
Benvenuti, Giacomo [2 ]
Rennison-Jones, Christian [2 ]
Bou-Zeid, Wassim [2 ]
Joly, Olivier [2 ]
Gerry, Stephen [3 ]
Fernandez, Claire [2 ]
Harston, George [2 ]
Devaraj, Anand [1 ]
机构：
[1] Royal Brompton Hosp, London, England
[2] Brainomix, Oxford, England
[3] Univ Oxford, Oxford, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.OA855
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 15 条
  • [1] The Automated E-ILD CT Algorithm Is More Prognostic Than FVC in the Serial Assessment of Patients With Non-IPF Fibrotic Interstitial Lung Disease
    George, P. M.
    Rennison-Jones, C.
    Benvenuti, G.
    Gupta, G.
    Joly, O.
    Gerry, S.
    Rajan, S.
    Jankharia, B.
    Fernandez, C.
    Harston, G.
    Devaraj, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Performance Evaluation and Validation of e-Lung in non-IPF fibrotic ILD
    George, Peter
    Dezfouli, Katharina Abbasi
    Kou, Yao
    Sifostratoudaki, Aliki
    Fernandez, Claire
    Ottink, Finja
    Bou-Zeid, Wassim
    Rennison-Jones, Christian
    Gerry, Stephen
    Joly, Olivier
    Harston, George
    Devaraj, Anand
    Kreuter, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [3] The automated e-Lung CT algorithm is more prognostic than lung function in patients with non IPF fibrotic ILD; a validation study
    George, Peter
    Rennison-Jones, Christian
    Benvenuti, Giacomo
    Bou-Zeid, Wassim
    Joly, Olivier
    Gerry, Stephen
    Fernandez, Claire
    Harston, George
    Devaraj, Anand
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] Patterns of progression in non-IPF fibrotic interstitial lung disease
    Wells, Athol U.
    CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (05) : 459 - 464
  • [5] Current Treatment of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease
    Opuni, Kwabena
    Kreuter, Michael
    Quaresma, Manuel
    Wijsenbeek, Marlies
    Olson, Amy
    Fischer, Aryeh
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 782 - 782
  • [6] Current Treatment of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease
    Kreuter, M.
    Olson, A.
    Fischer, A.
    Bendstrup, E.
    Mounir, B.
    Zouad-Lejour, L.
    Wells, C. D.
    Quaresma, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] Pirfenidone in patients with non-IPF progressive fibrotic interstitial lung diseases: expert guidance is urgently needed
    Wells, Athol
    LANCET RESPIRATORY MEDICINE, 2021, 9 (05): : 437 - 438
  • [8] IN NON-IPF FIBROSING ILD, E-LUNG BIOMARKERS ARE ASSOCIATED WITH THE FUTURE DEVELOPMENT OF PROGRESSIVE PULMONARY FIBROSIS INDEPENDENT OF UIP STATUS ON CT SCAN
    George, Peter
    Rennison-Jones, Christian
    Ottink, Finja
    Baggs, Rachel
    Sifostratoudaki, Aliki
    Fernandez, Claire
    Gerry, Stephen
    Harston, George
    Devaraj, Anand
    CHEST, 2024, 166 (04) : 3264A - 3265A
  • [9] Health care resources utilisation and costs in patients with non-IPF progressive fibrosing interstitial lung disease
    Olson, Amy
    Maher, Toby
    Salisbury, Margaret
    Acciai, Valentina
    Mounir, Baher
    Quaresma, Manuel
    Zouad-Lejour, Leila
    Wells, Christopher
    Fischer, Aryeh
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [10] Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
    Amy L. Olson
    Toby M. Maher
    Valentina Acciai
    Baher Mounir
    Manuel Quaresma
    Leila Zouad-Lejour
    Christopher D. Wells
    Lou De Loureiro
    Advances in Therapy, 2020, 37 : 3292 - 3298
12